Leptin treatment: Facts and expectations

Metabolism: Clinical and Experimental

Volumn 64, Issue 1, 2015, Pages 146-156

  Paz Filho, Gilberto ^a   Mastronardi, Claudio A ^a   Licinio, Julio ^b  

^a Biology and Environment   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Congenital leptin deficiency; Leptin; Metreleptin; Myalept; Obesity

Indexed keywords

LEPTIN; METRELEPTIN;

ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; DRUG HALF LIFE; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FAT MASS; FATTY LIVER; FOOD INTAKE; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMIC AMENORRHEA; HYPOTHALAMIC PITUITARY SOMATOTROPIC AXIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS PITUITARY THYROID AXIS; IMMUNITY; KIDNEY CLEARANCE; LEPTIN DEFICIENCY; LIPID METABOLISM; LIPODYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SUBSTITUTION THERAPY; WEIGHT REDUCTION; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; HORMONE SUBSTITUTION; METABOLISM; PROCEDURES;

ANIMALS; BODY WEIGHT; ENERGY METABOLISM; HORMONE REPLACEMENT THERAPY; HUMANS; LEPTIN;

EID: 84923955669     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.07.014     Document Type: Review

References (97)

1. R.S. Ahima Adipose tissue as an endocrine organ Obesity (Silver Spring) 14 Suppl. 5 2006 242S 249S
2. C.L. Boguszewski, G. Paz-Filho, and L.A. Velloso Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain Endokrynol Pol 61 2010 194 206
3. C.S. Mantzoros, F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, and S.Y. Kim Leptin in human physiology and pathophysiology Am J Physiol Endocrinol Metab 301 2011 E567 E584
4. G. Paz-Filho, M.L. Wong, and J. Licinio Ten years of leptin replacement therapy Obes Rev 12 2011 e315 e323
5. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
6. J.L. Halaas, K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, and D. Rabinowitz Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543 546
7. M.A. Pelleymounter, M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, and T. Boone Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 1995 540 543
8. I.S. Farooqi, S.A. Jebb, G. Langmack, E. Lawrence, C.H. Cheetham, and A.M. Prentice Effects of recombinant leptin therapy in a child with congenital leptin deficiency N Engl J Med 341 1999 879 884
9. M. Rosenbaum, and R.L. Leibel The role of leptin in human physiology N Engl J Med 341 1999 913 915
10. K. Chou, and C.M. Perry Metreleptin: first global approval Drugs 73 2013 989 997
11. Bristol-Myers Squibb Myalept Package Insert 2014
12. J.L. Chan, K. Lutz, E. Cochran, W.Y. Huang, Y. Peters, and C. Weyer Clinical effects of long-term metreleptin treatment in patients with lipodystrophy Endocr Pract 17 2011 922 932
13. M. Iwanishi, K. Ebihara, T. Kusakabe, M. Washiyama, J. Ito-Kobayashi, and F. Nakamura Primary intestinal follicular lymphoma and premature atherosclerosis in a japanese diabetic patient with atypical familial partial lipodystrophy Intern Med 53 2014 851 858
14. A. Aslam, D. Savage, and I.H. Coulson Acquired generalized lipodystrophy associated with peripheral T-cell lymphoma with cutaneous infiltration Int J Dermatol 2013 10.1111/ijd.12185 [Epub ahead of print]
15. Endocrinologic and Metabolic Drugs Advisory Committee Briefing Document 2013 [accessed 30/06/2014]. Available from http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/endocrinologicandmetabolicdrugsadvisorycommittee/ucm377929.pdf
16. I.S. Farooqi, G. Matarese, G.M. Lord, J.M. Keogh, E. Lawrence, and C. Agwu Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J Clin Invest 110 2002 1093 1103
17. J. Beltrand, N. Lahlou, T. Le Charpentier, G. Sebag, S. Leka, and M. Polak Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin Eur J Endocrinol 162 2010 1083 1091
18. I.S. Farooqi, and S. O'Rahilly Leptin: a pivotal regulator of human energy homeostasis Am J Clin Nutr 89 2009 980S 984S
19. W. Fatima, A. Shahid, M. Imran, J. Manzoor, S. Hasnain, and S. Rana Leptin deficiency and leptin gene mutations in obese children from Pakistan Int J Pediatr Obes 6 2011 419 427
20. W.T. Gibson, I.S. Farooqi, M. Moreau, A.M. DePaoli, E. Lawrence, and S. O'Rahilly Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy J Clin Endocrinol Metab 89 2004 4821 4826
21. C.T. Montague, I.S. Farooqi, J.P. Whitehead, M.A. Soos, H. Rau, and N.J. Wareham Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 1997 903 908
22. S. Saeed, T.A. Butt, M. Anwer, M. Arslan, and P. Froguel High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families Mol Genet Metab 106 2012 121 126
23. I. Mazen, M. El-Gammal, M. Abdel-Hamid, and K. Amr A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient Mol Genet Metab 97 2009 305 308
24. P. Fischer-Posovszky, J. von Schnurbein, B. Moepps, G. Lahr, G. Strauss, and T.F. Barth A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness J Clin Endocrinol Metab 95 2010 2836 2840
25. M. Ozata, I.C. Ozdemir, and J. Licinio Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects J Clin Endocrinol Metab 84 1999 3686 3695
26. G.J. Paz-Filho, T. Babikian, R. Asarnow, T. Delibasi, K. Esposito, and H.K. Erol Leptin replacement improves cognitive development PLoS One 3 2008 e3098
27. A. Strobel, T. Issad, L. Camoin, M. Ozata, and A.D. Strosberg A leptin missense mutation associated with hypogonadism and morbid obesity Nat Genet 18 1998 213 215
28. V.P. Andreev, G. Paz-Filho, M.L. Wong, and J. Licinio Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment Horm Metab Res 41 2009 142 151
29. K. Baicy, E.D. London, J. Monterosso, M.L. Wong, T. Delibasi, and A. Sharma Leptin replacement alters brain response to food cues in genetically leptin-deficient adults Proc Natl Acad Sci U S A 104 2007 18276 18279
30. S.M. Berman, G. Paz-Filho, M.L. Wong, M. Kohno, J. Licinio, and E.D. London Effects of leptin deficiency and replacement on cerebellar response to food-related cues Cerebellum 12 2013 59 67
31. I.S. Farooqi, E.T. Bullmore, J. Keogh, J. Gillard, S. O'Rahilly, and P.C. Fletcher Leptin regulates striatal regions and human eating behavior Science 317 2007 1355
32. S. Frank, M. Heni, A. Moss, J. von Schnurbein, S. Farooqi, and H.U. Haring Long-term stabilization effects of leptin on brain functions in a leptin-deficient patient PLoS One 8 2013 e65893
33. S. Frank, M. Heni, A. Moss, J. von Schnurbein, A. Fritsche, and H.U. Haring Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas J Clin Endocrinol Metab 96 2011 E1283 E1287
34. J.E. Galgani, F.L. Greenway, S. Caglayan, M.L. Wong, J. Licinio, and E. Ravussin Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients J Clin Endocrinol Metab 95 2010 851 855
35. K. Hedbacker, K. Birsoy, R.W. Wysocki, E. Asilmaz, R.S. Ahima, and I.S. Farooqi Antidiabetic effects of IGFBP2, a leptin-regulated gene Cell Metab 11 2010 11 22
36. K. Ishibashi, S.M. Berman, G. Paz-Filho, B. Lee, C. Robertson, and M.A. Mandelkern Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement Mol Psychiatry 17 2012 352 353
37. J. Licinio, S. Caglayan, M. Ozata, B.O. Yildiz, P.B. de Miranda, and F. O'Kirwan Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults Proc Natl Acad Sci U S A 101 2004 4531 4536
38. J. Licinio, L. Ribeiro, J.V. Busnello, T. Delibasi, S. Thakur, and R.M. Elashoff Effects of leptin replacement on macro- and micronutrient preferences Int J Obes (Lond) 31 2007 1859 1863
39. E.D. London, S.M. Berman, S. Chakrapani, T. Delibasi, J. Monterosso, and H.K. Erol Short-term plasticity of gray matter associated with leptin deficiency and replacement J Clin Endocrinol Metab 96 2011 E1212 E1220
40. J.A. Matochik, E.D. London, B.O. Yildiz, M. Ozata, S. Caglayan, and A.M. DePaoli Effect of leptin replacement on brain structure in genetically leptin-deficient adults J Clin Endocrinol Metab 90 2005 2851 2854
41. G. Paz-Filho, T. Delibasi, H.K. Erol, M.L. Wong, and J. Licinio Congenital leptin deficiency and thyroid function Thyroid Res 2 2009 11
42. G. Paz-Filho, K. Esposito, B. Hurwitz, A. Sharma, C. Dong, and V. Andreev Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients Am J Physiol Endocrinol Metab 295 2008 E1401 E1408
43. G.J. Paz-Filho, D. Andrews, K. Esposito, H.K. Erol, T. Delibasi, and M.L. Wong Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects Horm Metab Res 41 2009 164 167
44. G.J. Paz-Filho, A. Ayala, K. Esposito, H.K. Erol, T. Delibasi, and B.E. Hurwitz Effects of leptin on lipid metabolism Horm Metab Res 40 2008 572 574
45. G.J. Paz-Filho, T. Delibasi, H.K. Erol, M.L. Wong, and J. Licinio Cellular immunity before and after leptin replacement therapy J Pediatr Endocrinol Metab 22 2009 1069 1074
46. J. von Schnurbein, M. Heni, A. Moss, S.A. Nagel, J. Machann, and H. Muehleder Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl Horm Res Paediatr 79 2013 310 317
47. J. von Schnurbein, A. Moss, S.A. Nagel, H. Muehleder, K.M. Debatin, and I.S. Farooqi Leptin substitution results in the induction of menstrual cycles in an adolescent with leptin deficiency and hypogonadotropic hypogonadism Horm Res Paediatr 77 2012 127 133
48. D.A. Williamson, E. Ravussin, M.L. Wong, A. Wagner, A. Dipaoli, and S. Caglayan Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy Appetite 45 2005 75 80
49. J. Licinio, A.B. Negrao, C. Mantzoros, V. Kaklamani, M.L. Wong, and P.B. Bongiorno Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women Proc Natl Acad Sci U S A 95 1998 2541 2546
50. Y.H. Lee, F. Magkos, C.S. Mantzoros, and E.S. Kang Effects of leptin and adiponectin on pancreatic beta-cell function Metabolism 60 2011 1664 1672
51. K. Michalakis, G. Mintziori, A. Kaprara, B.C. Tarlatzis, and D.G. Goulis The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review Metabolism 62 2013 457 478
52. J. Van de Voorde, B. Pauwels, C. Boydens, and K. Decaluwe Adipocytokines in relation to cardiovascular disease Metabolism 62 2013 1513 1521
53. K.K. Koh, S.M. Park, and M.J. Quon Leptin and cardiovascular disease: response to therapeutic interventions Circulation 117 2008 3238 3249
54. E. Burgos-Ramos, L. Sackmann-Sala, E. Baquedano, D. Cruz-Topete, V. Barrios, and J. Argente Central leptin and insulin administration modulates serum cytokine- and lipoprotein-related markers Metabolism 61 2012 1646 1657
55. G. Paz-Filho, C. Mastronardi, C.B. Franco, K.B. Wang, M.L. Wong, and J. Licinio Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications Arq Bras Endocrinol Metabol 56 2012 597 607
56. U.H. Neumann, S. Chen, Y.Y. Tam, R.K. Baker, S.D. Covey, and P.R. Cullis IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice Endocrinology 155 2014 716 725
57. C.S. Mantzoros, M. Ozata, A.B. Negrao, M. Ziotopoulou, S. Caglayan, and M. Suchard Synchronicity of frequently sampled TSH and leptin concentrations in healthy adults and leptin deficient subjects: evidence for possible partial TSH regulation by leptin in humans J Clin Endocrinol Metab 86 2001 3284 3291
58. V. Simha Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy Expert Rev Endocrinol Metab 9 2014 205 212
59. J. Paruthi, N. Gill, and C.S. Mantzoros Adipokines in the HIV/HAART-associated lipodystrophy syndrome Metabolism 62 2013 1199 1205
60. R.V. Sekhar, F. Jahoor, D. Iyer, A. Guthikonda, J. Paranilam, and F. Elhaj Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome Metabolism 61 2012 1395 1403
61. J.P. Foo, and C.S. Mantzoros Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials Metabolism 61 2012 1331 1336
62. J.L. Chan, and C.S. Mantzoros Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa Lancet 366 2005 74 85
63. C.K. Welt, J.L. Chan, J. Bullen, R. Murphy, P. Smith, and A.M. DePaoli Recombinant human leptin in women with hypothalamic amenorrhea N Engl J Med 351 2004 987 997
64. S.H. Chou, J.P. Chamberland, X. Liu, G. Matarese, C. Gao, and R. Stefanakis Leptin is an effective treatment for hypothalamic amenorrhea Proc Natl Acad Sci U S A 108 2011 6585 6590
65. E. Sienkiewicz, F. Magkos, K.N. Aronis, M. Brinkoetter, J.P. Chamberland, and S. Chou Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women Metabolism 60 2011 1211 1221
66. G. Matarese, C. La Rocca, H.S. Moon, J.Y. Huh, M.T. Brinkoetter, and S. Chou Selective capacity of metreleptin administration to reconstitute CD4 + T-cell number in females with acquired hypoleptinemia Proc Natl Acad Sci U S A 110 2013 E818 E827
67. K.N. Aronis, K.N. Diakopoulos, C.G. Fiorenza, J.P. Chamberland, and C.S. Mantzoros Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans Diabetologia 54 2011 2358 2367
68. A.L. Mark Selective leptin resistance revisited Am J Physiol Regul Integr Comp Physiol 305 2013 R566 R581
69. S.B. Heymsfield, A.S. Greenberg, K. Fujioka, R.M. Dixon, R. Kushner, and T. Hunt Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA 282 1999 1568 1575
70. P.M. Zelissen, K. Stenlof, M.E. Lean, J. Fogteloo, E.T. Keulen, and J. Wilding Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial Diabetes Obes Metab 7 2005 755 761
71. J. Korner, R. Conroy, G. Febres, D.J. McMahon, I. Conwell, and W. Karmally Randomized double-blind placebo-controlled study of leptin administration after gastric bypass Obesity (Silver Spring) 21 2013 951 956
72. H.S. Moon, G. Matarese, A.M. Brennan, J.P. Chamberland, X. Liu, and C.G. Fiorenza Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance Diabetes 60 2011 1647 1656
73. R. Conroy, M. Girotra, E. Shane, D.J. McMahon, K.H. Pavlovich, and R.L. Leibel Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss Metabolism 60 2011 1222 1226
74. E. Ravussin, S.R. Smith, J.A. Mitchell, R. Shringarpure, K. Shan, and H. Maier Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy Obesity (Silver Spring) 17 2009 1736 1743
75. T.D. Muller, L.M. Sullivan, K. Habegger, C.X. Yi, D. Kabra, and E. Grant Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21 J Pept Sci 18 2012 383 393
76. G.J. Paz-Filho, A. Volaco, H.L. Suplicy, R.B. Radominski, and C.L. Boguszewski Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome Arq Bras Endocrinol Metabol 53 2009 1088 1095
77. I.S. Farooqi, J.M. Keogh, S. Kamath, S. Jones, W.T. Gibson, and R. Trussell Partial leptin deficiency and human adiposity Nature 414 2001 34 35
78. A.J. Kruger, C. Yang, K.L. Lipson, S.C. Pino, J.H. Leif, and C.M. Hogan Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats Autoimmunity 44 2011 137 148
79. R. Coppari, and C. Bjorbaek Leptin revisited: its mechanism of action and potential for treating diabetes Nat Rev Drug Discov 11 2012 692 708
80. B. Mittendorfer, J.F. Horowitz, A.M. DePaoli, M.A. McCamish, B.W. Patterson, and S. Klein Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes Diabetes 60 2011 1474 1477
81. H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, and F. Magkos Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals Endocr Rev 34 2013 377 412
82. R.J. Brown, E. Cochran, and P. Gorden Metreleptin improves blood glucose in patients with insulin receptor mutations J Clin Endocrinol Metab 98 2013 E1749 E1756
83. E.D. Javor, M.G. Ghany, E.K. Cochran, E.A. Oral, A.M. DePaoli, and A. Premkumar Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy Hepatology 41 2005 753 760
84. X.Y. Lu The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 7 2007 648 652
85. J.C. Garza, M. Guo, W. Zhang, and X.Y. Lu Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling Mol Psychiatry 17 2012 790 808
86. W. Lieb, A.S. Beiser, R.S. Vasan, Z.S. Tan, R. Au, and T.B. Harris Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging JAMA 302 2009 2565 2572
87. S.J. Greco, K.J. Bryan, S. Sarkar, X. Zhu, M.A. Smith, and J.W. Ashford Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease J Alzheimers Dis 19 2010 1155 1167
88. G. Paz-Filho, M.L. Wong, and J. Licinio The procognitive effects of leptin in the brain and their clinical implications Int J Clin Pract 64 2010 1808 1812
89. M.G. Myers Jr.; S.B. Heymsfield, C. Haft, B.B. Kahn, M. Laughlin, and R.L. Leibel Challenges and opportunities of defining clinical leptin resistance Cell Metab 15 2012 150 156
90. D. Cai Neuroinflammation and neurodegeneration in overnutrition-induced diseases Trends Endocrinol Metab 24 2013 40 47
91. J.P. Thaler, C.X. Yi, E.A. Schur, S.J. Guyenet, B.H. Hwang, and M.O. Dietrich Obesity is associated with hypothalamic injury in rodents and humans J Clin Invest 122 2012 153 162
92. A. Kleinridders, D. Schenten, A.C. Konner, B.F. Belgardt, J. Mauer, and T. Okamura MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity Cell Metab 10 2009 249 259
93. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity Cell 135 2008 61 73
94. A.S. Reed, E.K. Unger, L.E. Olofsson, M.L. Piper, M.G. Myers Jr.; and A.W. Xu Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis Diabetes 59 2010 894 906
95. M. Milanski, A.P. Arruda, A. Coope, L.M. Ignacio-Souza, C.E. Nunez, and E.A. Roman Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver Diabetes 61 2012 1455 1462
96. Z. Lu, G. Marcelin, F. Bauzon, H. Wang, H. Fu, and S.L. Dun pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location EMBO J 32 2013 844 857
97. H.S. Moon, J.P. Chamberland, K.N. Diakopoulos, C.G. Fiorenza, F. Ziemke, and B. Schneider Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans Diabetes Care 34 2011 132 138